TScan Therapeutics Inc.

1.26
-0.01 (-0.79%)
At close: Apr 02, 2025, 3:59 PM
1.25
-0.79%
After-hours: Apr 02, 2025, 07:28 PM EDT

TScan Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net Income -127.5M -89.22M -66.22M -48.63M -26.13M -13.66M
Depreciation & Amortization 4.11M 5.36M 5.14M 3.33M 1.23M 519K
Stock-Based Compensation 9.55M 5.21M 4.55M 2.52M 515K 240K
Other Working Capital 3.06M 17.66M -10.76M -5.91M 20.23M 138K
Other Non-Cash Items -2.03M -315K 260K 9.16M 2K 78K
Deferred Income Tax n/a n/a n/a -9.16M n/a n/a
Change in Working Capital 5.05M 17.61M -10.23M -5.9M 21.36M 299K
Operating Cash Flow -110.82M -61.36M -66.5M -48.68M -3.02M -12.52M
Capital Expenditures -3.83M -3.15M -4.22M -9.94M -4.24M -1.25M
Acquisitions n/a n/a n/a n/a n/a n/a
Purchase of Investments -241.44M -77.61M n/a n/a n/a n/a
Sales Maturities Of Investments 192.66M 20M n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a
Investing Cash Flow -52.61M -60.76M -4.22M -9.94M -4.24M -1.25M
Debt Repayment 15.31M n/a 29.35M n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 160.32M 93.03M -191K 291K 288K 5K
Financial Cash Flow 208.76M 135.44M 29.36M 189.67M 288K 34.81M
Net Cash Flow 45.33M 13.33M -41.37M 131.05M -6.97M 21.04M
Free Cash Flow -114.65M -64.5M -70.73M -58.62M -7.26M -13.77M